Trials / Unknown
UnknownNCT01478776
The Impact of Omega-3 Supplementation on Gene Expression in Type 2 Diabetics
The Impact of Omega-3 Supplementation on Acylation Stimulating Protein(ASP), Retinol-binding Protein 4 (RBP4) and Lipocalin-2 (LCN2) Gene Expression of ASP Receptor (C5L2) in WBC of Patient With Diabetes Type 2
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Tehran University of Medical Sciences · Academic / Other
- Sex
- All
- Age
- 30 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is the comparison between the effects of supplementation with omega-3 or placebo for 10 weeks in type 2 diabetics
Detailed description
Adipose tissue is recognized as an important endocrine organ in human. Not only it has function of storing unlimited energy but also its secretory roles is subject to intense research in recent years. Acylation stimulating protein(ASP), Retinol-binding protein 4 (RBP4) and lipocalin-2 (LCN2) are circulating adipokines elevated in diabetes. C5L2 is a G-protein-coupled receptor. activation of C5L2 by ASP, has been shown. Fatty acids may influence the expression of adipokines. Epidemiological studies showed that omega-3 reduce the development of insulin resistance and diabetes. Because fatty acids are the main component of adipose tissue, it is essential interest to clarify the biological effects of omega-3 on the expression of relevant adipokines.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | omega-3 | 4 cap 1 gr omega-3 per day for 10 weeks |
| DIETARY_SUPPLEMENT | placebo | patient with type 2 diabetes who receive 4 cap placebo/day for 10 weeks |
Timeline
- Start date
- 2011-12-01
- Primary completion
- 2013-03-01
- Completion
- 2013-09-01
- First posted
- 2011-11-23
- Last updated
- 2012-12-03
Locations
1 site across 1 country: Iran
Source: ClinicalTrials.gov record NCT01478776. Inclusion in this directory is not an endorsement.